Oxidized phospholipids stimulate production of stem cell factor via NRF2-dependent mechanisms
Tóm tắt
Receptor tyrosine kinase c-Kit and its ligand stem cell factor (SCF) regulate resident vascular wall cells and recruit circulating progenitors. We tested whether SCF may be induced by oxidized palmitoyl-arachidonoyl-phosphatidylcholine (OxPAPC) known to accumulate in atherosclerotic vessels. Gene expression analysis demonstrated OxPAPC-induced upregulation of SCF mRNA and protein in different types of endothelial cells (ECs). Elevated levels of SCF mRNA were observed in aortas of ApoE−/− knockout mice. ECs produced biologically active SCF because conditioned medium from OxPAPC-treated cells stimulated activation (phosphorylation) of c-Kit in naïve ECs. Induction of SCF by OxPAPC was inhibited by knocking down transcription factor NRF2. Inhibition or stimulation of NRF2 by pharmacological or molecular tools induced corresponding changes in SCF expression. Finally, we observed decreased levels of SCF mRNA in aortas of NRF2 knockout mice. We characterize OxPLs as a novel pathology-associated stimulus inducing expression of SCF in endothelial cells. Furthermore, our data point to transcription factor NRF2 as a major mediator of OxPL-induced upregulation of SCF. This mechanism may represent one of the facets of pleiotropic action of NRF2 in vascular wall.
Tài liệu tham khảo
Lennartsson J, Rönnstrand L (2012) Stem cell factor receptor/c-Kit: from basic science to clinical implications. Physiol Rev 92:1619–1649. https://doi.org/10.1152/physrev.00046.2011
Ding L, Saunders TL, Enikolopov G, Morrison SJ (2012) Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 481:457–462. https://doi.org/10.1038/nature10783
El-Agamy DS (2012) Targeting c-kit in the therapy of mast cell disorders: current update. Eur J Pharmacol 690:1–3. https://doi.org/10.1016/j.ejphar.2012.06.030
Broudy VC, Kovach NL, Bennett LG et al (1994) Human umbilical vein endothelial cells display high-affinity c-kit receptors and produce a soluble form of the c-kit receptor. Blood 83:2145–2152
Davis BN, Hilyard AC, Nguyen PH et al (2009) Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype. J Biol Chem 284:3728–3738. https://doi.org/10.1074/jbc.M808788200
Hollenbeck ST, Sakakibara K, Faries PL et al (2004) Stem cell factor and c-kit are expressed by and may affect vascular SMCs through an autocrine pathway. J Surg Res 120:288–294. https://doi.org/10.1016/j.jss.2004.01.005
Koenig A, Yakisan E, Reuter M et al (1994) Differential regulation of stem cell factor mRNA expression in human endothelial cells by bacterial pathogens: an in vitro model of inflammation. Blood 83:2836–2843
Miyamoto T, Sasaguri Y, Sasaguri T et al (1997) Expression of stem cell factor in human aortic endothelial and smooth muscle cells. Atherosclerosis 129:207–213
Matsui J, Wakabayashi T, Asada M et al (2004) Stem cell factor/c-kit signaling promotes the survival, migration, and capillary tube formation of human umbilical vein endothelial cells. J Biol Chem 279:18600–18607. https://doi.org/10.1074/jbc.M311643200
Fang S, Wei J, Pentinmikko N et al (2012) Generation of functional blood vessels from a single c-kit+ adult vascular endothelial stem cell. PLoS Biol 10:e1001407. https://doi.org/10.1371/journal.pbio.1001407
Wang C-H, Verma S, Hsieh I-C et al (2007) Stem cell factor attenuates vascular smooth muscle apoptosis and increases intimal hyperplasia after vascular injury. Arterioscler Thromb Vasc Biol 27:540–547. https://doi.org/10.1161/01.ATV.0000257148.01384.7d
Dentelli P, Rosso A, Balsamo A et al (2007) C-KIT, by interacting with the membrane-bound ligand, recruits endothelial progenitor cells to inflamed endothelium. Blood 109:4264–4271. https://doi.org/10.1182/blood-2006-06-029603
Torsney E, Mandal K, Halliday A et al (2007) Characterisation of progenitor cells in human atherosclerotic vessels. Atherosclerosis 191:259–264. https://doi.org/10.1016/j.atherosclerosis.2006.05.033
Hibbert B, Chen Y-X, O’Brien ER (2004) c-kit-immunopositive vascular progenitor cells populate human coronary in-stent restenosis but not primary atherosclerotic lesions. Am J Physiol Heart Circ Physiol 287:H518–H524. https://doi.org/10.1152/ajpheart.00002.2004
Tsai T-N, Kirton JP, Campagnolo P et al (2012) Contribution of stem cells to neointimal formation of decellularized vessel grafts in a novel mouse model. Am J Pathol 181:362–373. https://doi.org/10.1016/j.ajpath.2012.03.021
Shen YH, Hu X, Zou S et al (2012) Stem cells in thoracic aortic aneurysms and dissections: potential contributors to aortic repair. Ann Thorac Surg 93:1524–1533. https://doi.org/10.1016/j.athoracsur.2012.01.063
Montani D, Perros F, Gambaryan N et al (2011) C-kit-positive cells accumulate in remodeled vessels of idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 184:116–123. https://doi.org/10.1164/rccm.201006-0905OC
Ferlosio A, Arcuri G, Doldo E et al (2012) Age-related increase of stem marker expression influences vascular smooth muscle cell properties. Atherosclerosis 224:51–57. https://doi.org/10.1016/j.atherosclerosis.2012.07.016
Bochkov V, Gesslbauer B, Mauerhofer C et al (2016) Pleiotropic effects of oxidized phospholipids. Free Radic Biol Med. https://doi.org/10.1016/j.freeradbiomed.2016.12.034
Mauerhofer C, Philippova M, Oskolkova OV, Bochkov VN (2016) Hormetic and anti-inflammatory properties of oxidized phospholipids. Mol Aspects Med 49:78–90. https://doi.org/10.1016/j.mam.2016.02.003
Bochkov VN, Oskolkova OV, Birukov KG et al (2010) Generation and biological activities of oxidized phospholipids. Antioxid Redox Signal 12:1009–1059. https://doi.org/10.1089/ars.2009.2597
Jyrkkanen H-K, Kansanen E, Inkala M et al (2008) Nrf2 regulates antioxidant gene expression evoked by oxidized phospholipids in endothelial cells and murine arteries in vivo. Circ Res 103:e1–e9. https://doi.org/10.1161/CIRCRESAHA.108.176883
Oskolkova OV, Afonyushkin T, Leitner A et al (2008) ATF4-dependent transcription is a key mechanism in VEGF up-regulation by oxidized phospholipids: critical role of oxidized sn-2 residues in activation of unfolded protein response. Blood 112:330–339. https://doi.org/10.1182/blood-2007-09-112870
Oskolkova OV, Afonyushkin T, Preinerstorfer B et al (2010) Oxidized phospholipids are more potent antagonists of lipopolysaccharide than inducers of inflammation. J Immunol 185:7706–7712. https://doi.org/10.4049/jimmunol.0903594
Gargalovic PS, Imura M, Zhang B et al (2006) Identification of inflammatory gene modules based on variations of human endothelial cell responses to oxidized lipids. Proc Natl Acad Sci U S A 103:12741–12746. https://doi.org/10.1073/pnas.0605457103
Flanagan JG, Chan DC, Leder P (1991) Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the Sld mutant. Cell 64:1025–1035
Li R, Chen W, Yanes R et al (2007) OKL38 is an oxidative stress response gene stimulated by oxidized phospholipids. J Lipid Res 48:709–715. https://doi.org/10.1194/jlr.M600501-JLR200
Afonyushkin T, Oskolkova OV, Binder BR, Bochkov VN (2011) Involvement of CK2 in activation of electrophilic genes in endothelial cells by oxidized phospholipids. J Lipid Res 52:98–103. https://doi.org/10.1194/jlr.M009480
Pulkkinen KH, Ylä-Herttuala S, Levonen A-L (2011) Heme oxygenase 1 is induced by miR-155 via reduced BACH1 translation in endothelial cells. Free Radic Biol Med 51:2124–2131. https://doi.org/10.1016/j.freeradbiomed.2011.09.014
Dhakshinamoorthy S, Jain AK, Bloom DA, Jaiswal AK (2005) Bach1 competes with Nrf2 leading to negative regulation of the antioxidant response element (ARE)-mediated NAD(P)H:quinone oxidoreductase 1 gene expression and induction in response to antioxidants. J Biol Chem 280:16891–16900. https://doi.org/10.1074/jbc.M500166200
Buzby JS, Knoppel EM, Cairo MS (1994) Coordinate regulation of Steel factor, its receptor (Kit), and cytoadhesion molecule (ICAM-1 and ELAM-1) mRNA expression in human vascular endothelial cells of differing origins. Exp Hematol 22:122–129
Lee S, Birukov KG, Romanoski CE et al (2012) Role of phospholipid oxidation products in atherosclerosis. Circ Res 111:778–799. https://doi.org/10.1161/CIRCRESAHA.111.256859
Kovanen PT (2007) Mast cells: multipotent local effector cells in atherothrombosis. Immunol Rev 217:105–122. https://doi.org/10.1111/j.1600-065X.2007.00515.x
Heikkilä HM, Trosien J, Metso J et al (2010) Mast cells promote atherosclerosis by inducing both an atherogenic lipid profile and vascular inflammation. J Cell Biochem 109:615–623. https://doi.org/10.1002/jcb.22443
Smith DD, Tan X, Raveendran VV et al (2012) Mast cell deficiency attenuates progression of atherosclerosis and hepatic steatosis in apolipoprotein E-null mice. Am J Physiol Heart Circ Physiol 302:H2612–H2621. https://doi.org/10.1152/ajpheart.00879.2011
Sun J, Sukhova GK, Wolters PJ et al (2007) Mast cells promote atherosclerosis by releasing proinflammatory cytokines. Nat Med 13:719–724. https://doi.org/10.1038/nm1601
Afonyushkin T, Oskolkova OV, Philippova M et al (2010) Oxidized phospholipids regulate expression of ATF4 and VEGF in endothelial cells via NRF2-dependent mechanism: novel point of convergence between electrophilic and unfolded protein stress pathways. Arterioscler Thromb Vasc Biol 30:1007–1013. https://doi.org/10.1161/ATVBAHA.110.204354
Watson AD, Leitinger N, Navab M et al (1997) Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J Biol Chem 272:13597–13607
Baker A, Saltik M, Lehrmann H et al (1997) Polyethylenimine (PEI) is a simple, inexpensive and effective reagent for condensing and linking plasmid DNA to adenovirus for gene delivery. Gene Ther 4:773–782. https://doi.org/10.1038/sj.gt.3300471